Marc Banjak's most recent trade in iBio Inc was a trade of 12,500 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on March 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| iBio Inc | Marc Banjak | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 26 Mar 2026 | 12,500 | 23,566 (0%) | 0% | 1.6 | 20,531 | Common Stock |
| iBio Inc | Marc Banjak | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 26 Mar 2026 | 1,434 | 25,000 (0%) | 0% | 1.8 | 2,524 | Common Stock |
| iBio Inc | Marc Banjak | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 146,000 | 146,000 | - | - | Stock Option (right to buy) | |
| iBio Inc | Marc Banjak | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2025 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| iBio Inc | Banjak Marc | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 71,000 | 71,000 | - | - | Stock Option (right to buy) | |
| iBio Inc | Marc Banjak | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 2.72 per share. | 10 Jan 2025 | 9,191 | 11,066 (0%) | 0% | 2.7 | 25,000 | Common Stock |